Zobrazeno 1 - 10
of 172
pro vyhledávání: ''
Autor:
Andrey Sivkov, Svetlana Sivkova, Roman V. Gorenkov, Sergey Sivkov, Natalya P. Chernus, Tamara Savina
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-9 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background To determine the effect of genetic polymorphism of drug transporters on the efficacy of treatment with Rosuvastatin, Atorvastatin and Simvastatin in patients with hyperlipidemia. Methods The study consists of 180 patients, aged 40–75 yea
Autor:
Chang Liu, Xuejiao Xing, Xiao-Lei Shen, Ming-Hao Ge, Dong-zhuo Wei, Dan-meng Zheng, Ding-wen Jiang, Zhen-ni An
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-19 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Acylcarnitine is an intermediate product of fatty acid oxidation. It is reported to be closely associated with the occurrence of diabetic cardiomyopathy (DCM). However, the mechanism of acylcarnitine affecting myocardial disorders is yet t
Autor:
Jiacheng Lai, Qingtong Wang, Meili Dong, Bin Li, Jingshu Ni, Yikun Wang, Chongjian Huang, Yongsheng Han
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-9 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Lipid management is the first line of treatment for decreasing the incidence of cardiovascular events in patients with coronary heart disease (CHD), and a variety of indicators are used to evaluate lipid management. This work analyses the
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-11 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Limited data are available for validation of low-density lipoprotein cholesterol (LDL) calculation (LDLcal) in the adult Korean population. The aim of this study was to develop and validate a new equation for LDLcal and to compare it with
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-11 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Dyslipidemia is a predisposing factor for coronary heart disease (CHD). High-intensity statin therapy is recommended as secondary prevention. ABCB1 and SLCO1B1 genes influence the efficacy and safety of statins. Xinjiang is a multi-ethnic
Autor:
Cheng Zhang, Liu Lu, Yukai Xiang, Yulong Yang, Xiangyu Kong, Ruiqi Lu, Chuanqi He, Jingli Cai, Bosen Zhang
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-10 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Pancreaticobiliary reflux (PBR) causes chronic inflammation of the gallbladder mucosa and changes in the bile components, which are known to promote gallstone formation. This study aimed to investigate the bile biochemistry changes in gall
Autor:
Wang, Saibin
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-7 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background The studies, investigating the association of low-density lipoprotein cholesterol (LDL-C) with metabolic syndrome (MetS) are limited with controversial conclusions. Therefore, this study aimed at revealing the specific relationship between
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-12 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background The inflammatory response plays essential roles in the pathological process and prognosis of Parkinson’s disease (PD). This research investigated the predictive value of the neutrophil to high-density lipoprotein ratio (NHR), neutrophil
Autor:
Shi Cheng, Guibin Yao, Changlin Yang, Zhihao Yu, Xia Qian, Xuesong Bai, Xiaodong Tian, Yamin Zheng, Yue Huang, Wei Gao
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-6 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background The purpose of this study was to assess the risk factors for cholesterol polyp formation in the gallbladder. Methods This was a multicenter retrospective study based on pathology. From January 2016 to December 2019, patients who underwent
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-17 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background The association of circulating lipids with clinical outcomes of drug-resistant castration-resistant prostate cancer (DR-CRPC) is not fully understood. While it is known that increases in select lipids correlate to decreased survival, neith